Wikipedia -WSS

Wikipedia

author：explore 2025-10-01 22:16:24 - browse：318

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Today, we explore the future of obesity drugs and how they’re named, we chat with CRISPR pioneers about what it’s like to see the technology approved for human use, and more.

The need-to-know this morning:
• Bayer said it prematurely stopped a Phase 3 study in stroke prevention after independent monitors concluded its experimental blood-thinning medicine, called asundexian, showed inferior efficacy compared to a standard treatment. The asundexian study setback is a significant blow to Bayer’s effort to revamp its drug-development pipeline, analysts said.
• Carmot Therapeutics filed paperwork Friday for an initial public offering of undisclosed size. The Berkeley, Calif.-based company is developing drugs that target GLP-1 and GIP to treat diabetes and obesity, similar to Novo Nordisk’s Ozempic/Wegovy and Eli Lilly’s Mounjaro/Zepbound.
• Bristol Myers Squibb and 2Seventy Bio said the FDA will not complete an on-time review of its application seeking to expand the use of Abecma, their CAR-T therapy for multiple myeloma. Instead, the FDA will convene an advisory panel meeting — date to be determined — to examine survival data from an Abecma clinical trial.
• The U.K. and the pharmaceutical industry have reached a deal on a five-year plan outlining how the health system pays for drugs, as the country tries to keep a lid on its medicines spending while simultaneously building up its life sciences industry. STAT’s Andrew Joseph has more here.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： Shifting the focus from loneliness to social health

WSS

GOP inquiry over gain

ASCO: AstraZeneca says CAR

ASCO: Palliative care found as helpful given virtually as in person

GOP inquiry over gain

Why do we get seasonal allergies?

Brazil's Jair Bolsonaro is barred from running for office until 2030

focus

Wikipedia

hotspot

Medical records are filled with copy

Ultragenyx gene therapy for rare liver ailment succeeds in late

United colonoscopy coverage change 'may cost lives,' doctors say

Change Healthcare can notify patients about the breach, HHS says

What does generative AI mean for health care? We asked experts

GOP hopefuls to address prominent, controversial group questioning what's taught in schools

What does generative AI mean for health care? We asked experts

Biden slams SCOTUS affirmative action decision: 'Discrimination still exists in America'

Duchenne breakthrough therapy leaves behind pioneering families

Woman returns to dialysis after doctors remove transplanted pig kidney

hotspot

Wildfire smoke map: Which US cities are forecast to be impacted by fires burning in Canada

Eating disorder hotline's move to chatbot carried cost for volunteers

Ukrainian soldiers say they owe lives to US

ASCO24: AstraZeneca won cancer’s big meeting. Can it fulfill its $80B ambition?

Eating disorder hotline's move to chatbot carried cost for volunteers

How to increase colonoscopy rates? Looks like an AI can help

Wikipedia

knowledge

focus

focus